Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Patch for Cardiovascular Markers in RLS
NCT01823770Phase 4Completed
- Sponsor
- CHU Montpellier
- Start
- Nov 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rotigotine in restless legs syndrome (RLS), sponsored by CHU Montpellier. Started Nov 2012; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01823770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823770.